Suspension of trading
Valuation Exscientia plc
Stocks
EXAI
US30223G1022
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/11/24 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/11/24 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Company Valuation: Exscientia plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 1,757 | 543.6 | 628.7 |
| Change | - | -69.06% | 15.67% |
| Enterprise Value (EV) 1 | 1,200 | 51.65 | 284.6 |
| Change | - | -95.69% | 451% |
| P/E | -14.8x | -4.55x | -4.28x |
| PBR | 3.11x | 1.14x | 1.78x |
| PEG | -0x | 3.03x | -0.2x |
| Capitalization / Revenue | 64.2x | 20x | 31.3x |
| EV / Revenue | 43.9x | 1.9x | 14.2x |
| EV / EBITDA | -23.4x | -0.32x | -1.75x |
| EV / EBIT | -22x | -0.31x | -1.63x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.9871 | -0.9722 | -1.175 |
| Distribution rate | - | - | - |
| Net sales 1 | 27.36 | 27.22 | 20.08 |
| EBITDA 1 | -51.31 | -159.9 | -162.5 |
| EBIT 1 | -54.64 | -167.6 | -174.5 |
| Net income 1 | -49.23 | -118.7 | -146 |
| Net Debt 1 | -557 | -491.9 | -344.1 |
| Reference price 2 | 14.593 | 4.424 | 5.032 |
| Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 |
| Announcement Date | 3/23/22 A | 3/23/23 A | 3/21/24 A |
1GBP in Million2GBP
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 633M | ||
| 32.25x | 5.76x | 17.3x | 1.02% | 46.86B | ||
| -23.62x | 354.58x | -21.66x | -.--% | 40.23B | ||
| 48.91x | 4.94x | 31.87x | -.--% | 36.23B | ||
| 25.32x | 2.8x | 12.1x | -.--% | 34.72B | ||
| 27.42x | 8.04x | 20.17x | 0.41% | 27.89B | ||
| 34.31x | 5.61x | 25.58x | -.--% | 16.79B | ||
| 22.12x | 1.95x | 8.48x | 1.19% | 13.12B | ||
| 23.43x | 1.87x | 11.34x | -.--% | 12.7B | ||
| Average | 23.77x | 48.19x | 13.15x | 0.33% | 25.46B | |
| Weighted average by Cap. | 22.49x | 66.41x | 12.08x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EXAI Stock
- Valuation Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
















